Clinical Trial Update: A Study to Assess the Safety and Efficacy of a Tacrolimus Based Immunosuppressive Regimen in Stable Kidney Transplant Recipients Converted From Cyclosporine Based Immunosuppressive Regimen [Phase 4]

View source ↗

Summary

This is an update on a Phase 4 trial evaluating a tacrolimus-based immunosuppressive regimen in stable kidney transplant recipients converted from cyclosporine;…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplantation

Drugs mentioned

• Tacrolimus (Tacrolimus)

Snippet

Sponsor: Astellas Pharma Korea, Inc. | Conditions: Kidney Transplantation | Phase 4 | Status: TERMINATED